Advanced Solid Tumors | Norton Healthcare

Indication: Advanced Solid Tumors

A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors

Sub-indication: Miscellaneous Malignancies

Drug Study

Principal Investigator: John Hamm, M.D.
Norton Cancer Institute

Sponsor: Astellas Pharma Global Development Inc.

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.